CB Biotechnology | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

5,704 results for “CB Biotechnology”

Trials

View all 151 →

BIOtechnology Applied to Renal TRansplantation With IMmunobiogram

443 participants · First posted Apr 18, 2023

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

210 participants · First posted Feb 26, 2014

Study of the Glutaminase Inhibitor CB-839 in Leukemia

43 participants · First posted Feb 26, 2014

Drugs

View all 975 →

CB-125

CB-201

CB-301

Organizations

View all 478 →

Puma Biotechnology

United States

MAIA Biotechnology

United States

Nautilus Biotechnology

United States

News

View all 4100 →

Theratechnologies Agrees to $254 Million Private Acquisition by CB Biotechnology

FDA Grants Fast Track Designations to Caribou Biosciences' CB-010 and CB-012 for Refractory SLE and AML

Caribou Biosciences Launches Phase 1 Trial of CB-010 in Lupus and Outlines 2025 Milestones

Page 1 of 571